LeonaBio, Inc. (LONA): Shareholders' Equity
$27.79M
As of 2025-12-31
$33.59M
As of 2026-06-30
-50.9%
3-year compound annual growth
-36.7%
5-year compound annual growth
| Period ended | Shareholders' Equity | Change YoY | Source filing |
|---|---|---|---|
| 2025-12-31 | $27.79M | -38.0% | 2026-03-31, Balance as of period end |
| 2024-12-31 | $44.84M | -65.6% | 2026-03-31, Balance as of period end |
| 2023-12-31 | $130.19M | -44.6% | 2025-02-27, Balance as of period end |
| 2022-12-31 | $235.14M | -26.8% | 2024-02-22, Balance as of period end |
| 2021-12-31 | $321.08M | +17.1% | 2023-03-23, Balance as of period end |
| 2020-12-31 | $274.28M | n/m | 2022-03-28, Balance as of period end |
| 2019-12-31 | -$19.72M | n/a | 2021-03-25, Balance as of period end |
Shareholders' Equity at similar companies
| Company | Year ended | Shareholders' Equity | Change YoY |
|---|---|---|---|
| LeonaBio, Inc. (LONA) | 2025-12-31 | $27.79M | -38.0% |
| aTYR PHARMA INC (ATYR) | 2025-12-31 | $67.48M | -3.6% |
| IRulya Therapeutics Inc. (IRLA) | 2025-12-31 | -$35.71M | n/m |
| Aligos Therapeutics, Inc. (ALGS) | 2025-12-31 | $53.55M | n/m |
| Surrozen, Inc. (SRZN) | 2025-12-31 | -$187.76M | n/m |
| Protalix BioTherapeutics, Inc. (PLX) | 2025-12-31 | $48.23M | +11.6% |
| Anavex Life Sciences Corp. (AVXL) | 2025-09-30 | $94.87M | -21.1% |
| Alpha Cognition Inc. (ACOG) | 2025-12-31 | $62.53M | +59.9% |
| Armata Pharmaceuticals, Inc. (ARMP) | 2025-12-31 | -$218.60M | n/m |
Compare LONA, ATYR, IRLA, ALGS side by side · Screen every company in Biological Products, (No Diagnostic Substances) ↗